title: Insulin sensitivity regulates cholesterol metabolism to a greater extent than obesity: lessons from the METSIM Study.
abstract: Cholesterol synthesis is upregulated and absorption downregulated in insulin resistance and in type 2 diabetes. We investigated whether alterations in cholesterol metabolism are observed across the glucose tolerance status, from normoglycemia through impaired glucose tolerance to type 2 diabetes, in 781 randomly selected men 45 to 70 years of age from a population-based Metabolic Syndrome in Men Study. Cholesterol metabolism was assayed using surrogate serum markers, squalene, and noncholesterol sterols. The study population was classified into subgroups according to glucose tolerance as follows: normoglycemia, impaired fasting glucose, impaired glucose tolerance, and type 2 diabetes. LDL cholesterol did not differ between the groups. Cholesterol synthesis markers were lowest and absorption markers highest in normoglycemia. Sitosterol was lower in subjects with impaired fasting glucose compared with normoglycemic subjects (113 +/- 7 vs. 136 +/- 3 10(2) mumol/mmol of cholesterol, P < 0.05). LDL cholesterol was not associated with lathosterol/sitosterol ratio, a marker of cholesterol metabolism. Peripheral insulin sensitivity evaluated by the Matsuda index was associated with the lathosterol/sitosterol ratio in the entire population (r = -0.457, P < 0.001) and with that of lathosterol/cholestanol independently of obesity. In conclusion, cholesterol metabolism was altered already from subjects with impaired fasting glucose. Upregulated cholesterol synthesis was associated with peripheral insulin resistance independent of obesity.
authors.affiliation: Department of Clinical Nutrition, University of Eastern Finland, PO Box 1627, FI-70211 Kuopio, Finland. helena.gylling@uef.fi
authors.forename: Helena
authors.initials: H
authors.lastname: Gylling
authors.forename: Maarit
authors.initials: M
authors.lastname: Hallikainen
authors.forename: Jussi
authors.initials: J
authors.lastname: Pihlajamäki
authors.forename: Piia
authors.initials: P
authors.lastname: Simonen
authors.forename: Johanna
authors.initials: J
authors.lastname: Kuusisto
authors.forename: Markku
authors.initials: M
authors.lastname: Laakso
authors.forename: Tatu A
authors.initials: TA
authors.lastname: Miettinen
mesh_terms: D000042:Absorption; D000368:Aged; D015415:Biomarkers / Q000097:blood; D004083:Cholestanol / Q000097:blood; D002784:Cholesterol / Q000378:metabolism*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000453:epidemiology* / Q000378:metabolism*; D005947:Glucose / Q000378:metabolism; D006801:Humans; D007328:Insulin / Q000378:metabolism*; D016014:Linear Models; D008297:Male; D024821:Metabolic Syndrome / Q000453:epidemiology*; D008875:Middle Aged; D009765:Obesity / Q000097:blood / Q000378:metabolism*; D010840:Phytosterols / Q000097:blood; D013185:Squalene / Q000097:blood
chemical_list: D015415:Biomarkers; D007328:Insulin; D010840:Phytosterols; D013185:Squalene; D004083:Cholestanol; D002784:Cholesterol; D005947:Glucose